Drawing for GADEA BIOPHARMA

USPTO serial 79117128

GADEA BIOPHARMA

Reviewed by CopyMark Law Group

Reg. 4366477Status 404
Filing date
Status date
Registration date
Jul 16, 2013
Examiner
KEARNEY, COLLEEN
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GADEA BIOPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arturo Perez-Guerrero

Arturo Perez-Guerrero MARCAS ESTADOS UNIDOSP.O. Box 9024163San Juan, PR 00902-4163

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the treatment of inflammatory disorder, allergy prevention and treatment, dermatological and immune system diseases and disorders, prevention and treatment of disorders of the immune system, the metabolic system, the musculoskeletal system, the genitourinary system, dermatitis, eczema, rhinitis, pruritus, for cancer prevention and treatment, treatment of respiratory diseases and asthma, eye care and eye diseases and disorders, glaucoma and management of ocular hypertension; [ sanitary preparations for medical purposes; food for babies; medical plasters, materials for dressings, namely, bandages, wadding; material for dental fillings and dental impressions; all purpose disinfectants; pesticides; herbicides; ] anti-inflammatory preparations, contraceptive preparations, namely, [ oral contraceptives, ] dermatological pharmaceutical preparations, [ fungicides, ] hormones for medical purposes, anti-allergy pharmaceutical preparations and substances, pharmaceutical preparations for skin care, pharmaceutical preparations for prevention and treatment of disorders of the immune system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system; pharmaceutical preparations for the treatment of diseases and disorders, namely, dermatitis, eczema, rhinitis, pruritus, respiratory, hormone, dermatological and immune system diseases and disorders, inflammatory disorders, for use in dermatology; pharmaceutical preparations for allergy treatment of rhinitis and asthma; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for cancer prevention and treatment; pharmaceutical preparations for the treatment of respiratory diseases and asthma, steroidsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 8, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jan 8, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 24, 2021INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 27, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 27, 2021INPCINVALIDATION PROCESSED—
Mar 21, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 22, 2020NC71NOTICE OF CANCELLATION SEC. 71 E-MAILED—
Jul 21, 2020C71TCANCELLED SECTION 71—
Jan 19, 2020PR71POST REGISTRATION ACTION MAILED - SEC.71—
Jan 19, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 30, 2019ES71TEAS SECTION 71 RECEIVED—
Jul 16, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 13, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 18, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 17, 2013FIMPFINAL DISPOSITION PROCESSED—
Oct 16, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 16, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2013GPNXNOTIFICATION PROCESSED BY IB—
May 6, 2013DOCKASSIGNED TO EXAMINER—
Apr 30, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 10, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 10, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 26, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2013ALIEASSIGNED TO LIE—
Mar 13, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 12, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 12, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 12, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 12, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2012RFNTREFUSAL PROCESSED BY IB—
Oct 5, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 5, 2012RFRRREFUSAL PROCESSED BY MPU—
Oct 5, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 4, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2012DOCKASSIGNED TO EXAMINER—
Sep 25, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 21, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 20, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance